Sharon Gray

2.3k total citations · 1 hit paper
31 papers, 1.2k citations indexed

About

Sharon Gray is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Sharon Gray has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 13 papers in Microbiology and 9 papers in Infectious Diseases. Recurrent topics in Sharon Gray's work include Pneumonia and Respiratory Infections (21 papers), Respiratory viral infections research (18 papers) and Bacterial Infections and Vaccines (13 papers). Sharon Gray is often cited by papers focused on Pneumonia and Respiratory Infections (21 papers), Respiratory viral infections research (18 papers) and Bacterial Infections and Vaccines (13 papers). Sharon Gray collaborates with scholars based in United States, United Kingdom and Costa Rica. Sharon Gray's co-authors include Luis Jódar, Bradley K. Ackerson, Srinivas Rao Valluri, John M. McLaughlin, Vennis Hong, Sara Y. Tartof, Oluwaseye Ayoola Ogun, Joann M. Zamparo, Timothy B. Frankland and Jeff Slezak and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Sharon Gray

29 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

2021 727 citations Sara Y. Tartof, Jeff Slezak et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon Gray United States	12	775	422	393	223	119	31	1.2k
Amadea Britton United States	15	968 1.2×	569 1.3×	444 1.1×	190 0.9×	81 0.7×	23	1.5k
Zundong Yin China	19	420 0.5×	663 1.6×	268 0.7×	131 0.6×	155 1.3×	82	1.2k
Clayton Chiu Australia	17	281 0.4×	627 1.5×	249 0.6×	81 0.4×	144 1.2×	30	1.0k
Danielle Moulia United States	16	788 1.0×	355 0.8×	424 1.1×	123 0.6×	15 0.1×	31	1.4k
Zhijie An China	18	284 0.4×	472 1.1×	294 0.7×	147 0.7×	28 0.2×	69	898
Iván Martínez‐Baz Spain	23	440 0.6×	967 2.3×	327 0.8×	254 1.1×	17 0.1×	77	1.3k
Amy Blain United States	16	340 0.4×	559 1.3×	337 0.9×	66 0.3×	531 4.5×	33	1.1k
Waasila Jassat South Africa	16	517 0.7×	213 0.5×	127 0.3×	154 0.7×	33 0.3×	54	956
Gang Zeng China	11	1.1k 1.5×	234 0.6×	380 1.0×	118 0.5×	12 0.1×	19	1.3k
Carmit Rubin Israel	13	1.1k 1.5×	85 0.2×	318 0.8×	207 0.9×	25 0.2×	28	1.4k

Countries citing papers authored by Sharon Gray

Since Specialization

Citations

This map shows the geographic impact of Sharon Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Gray more than expected).

Fields of papers citing papers by Sharon Gray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Gray. The network helps show where Sharon Gray may publish in the future.

Co-authorship network of co-authors of Sharon Gray

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Gray. A scholar is included among the top collaborators of Sharon Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Gray. Sharon Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramírez, Julio A., Frederick J. Angulo, Ruth Carrico, et al.. (2023). Misdiagnosis of Clostridioides difficile Infections by Standard-of-Care Specimen Collection and Testing among Hospitalized Adults, Louisville, Kentucky, USA, 2019–20201. Emerging infectious diseases. 29(5). 919–928. 3 indexed citations

Miyazaki, Taiga, Katsuji Hirano, Kiyoshi Ichihara, et al.. (2023). Community-Acquired Pneumonia Incidence in Adults Aged 18 Years and Older in Goto City, Japan. 1(2). 100007–100007. 5 indexed citations

Hyams, Catherine, Elizabeth Begier, María García González, et al.. (2022). Incidence of acute lower respiratory tract disease hospitalisations, including pneumonia, among adults in Bristol, UK, 2019, estimated using both a prospective and retrospective methodology. BMJ Open. 12(6). e057464–e057464. 8 indexed citations

Tateda, Kazuhiro, Satoshi Yoshizumi, Ping Zhang, et al.. (2022). Population-based incidence of hospitalized Clostridioides difficile infection among older adults in Ota-ku, Japan: A prospective surveillance study. Anaerobe. 76. 102607–102607. 5 indexed citations

Angulo, Frederick J., Ruth Carrico, Stephen Furmanek, et al.. (2022). Frequency of stool specimen collection and testing for Clostridioides difficile of hospitalized adults and long-term care facility residents with new-onset diarrhea in Louisville, Kentucky. International Journal of Infectious Diseases. 120. 196–200. 3 indexed citations

Tartof, Sara Y., Jeff Slezak, Laura Puzniak, et al.. (2022). Effectiveness of a third dose of BNT162b2 mRNA COVID-19 vaccine in a large US health system: A retrospective cohort study. The Lancet Regional Health - Americas. 9. 100198–100198. 80 indexed citations

Tartof, Sara Y., Jeff Slezak, Heidi Fischer, et al.. (2021). Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. The Lancet. 398(10309). 1407–1416. 727 indexed citations breakdown →

Istúriz, Raúl, Lindsay R. Grant, Sharon Gray, et al.. (2021). Expanded Analysis of 20 Pneumococcal Serotypes Associated With Radiographically Confirmed Community-acquired Pneumonia in Hospitalized US Adults. Clinical Infectious Diseases. 73(7). 1216–1222. 41 indexed citations

Tartof, Sara Y., Jeff Slezak, Heidi Fischer, et al.. (2021). Six-Month Effectiveness of BNT162B2 mRNA COVID-19 Vaccine in a Large US Integrated Health System: A Retrospective Cohort Study. SSRN Electronic Journal. 16 indexed citations

10.

Angulo, Frederick J., Senen Pena, Ruth Carrico, et al.. (2020). Frequency of Testing for Clostridioides difficile in Adults Hospitalized with Diarrhea in Louisville, Kentucky. Infection Control and Hospital Epidemiology. 41(S1). s444–s444. 1 indexed citations

11.

Gray, Sharon, et al.. (2016). Prospective, Population-Based Surveillance of the Burden of Streptococcus pneumoniae in Community-Acquired Pneumonia in Older Adults, Chrzanów County, Poland, 2010 to 2012. Advances in respiratory medicine. 84(2). 95–103. 4 indexed citations

12.

Casez, Pierre, Jérôme Fauconnier, Elane M. Gutterman, et al.. (2015). Longitudinal DRG-based survey of all-cause and pneumococcal pneumonia and meningitis for inpatients in France (2005–2010). Médecine et Maladies Infectieuses. 45(11-12). 446–455. 11 indexed citations

13.

Ludwig, Endre, et al.. (2014). Clinical burden of multi-cause and pneumococcal pneumonia, meningitis, and septicemia in Hungary. Results of a retrospective study (2006–2011). Orvosi Hetilap. 155(36). 1426–1436. 5 indexed citations

14.

Sherwin, Robert, Sharon Gray, Paul C. McGovern, et al.. (2013). Distribution of 13-Valent Pneumococcal Conjugate Vaccine Streptococcus pneumoniae Serotypes in US Adults Aged >=50 Years With Community-Acquired Pneumonia. The Journal of Infectious Diseases. 208(11). 1813–1820. 72 indexed citations

15.

Arguedas, Adriano, Arturo Abdelnour, Carolina Soley, et al.. (2012). Prospective epidemiologic surveillance of invasive pneumococcal disease and pneumonia in children in San José, Costa Rica. Acta Médica Costarricense. 54(4). 252–261. 1 indexed citations

16.

Andrade, Adriano de Oliveira, Adriano Arguedas, Ruth Minamisava, et al.. (2012). Bacteriology of Community-acquired Invasive Disease Found in a Multicountry Prospective, Population-based, Epidemiological Surveillance for Pneumococcus in Children in Latin America. The Pediatric Infectious Disease Journal. 31(12). 1312–1314. 4 indexed citations

17.

Ovalle, Oscar, et al.. (2012). Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia. Vaccine. 30(40). 5886–5892. 45 indexed citations

18.

Arguedas, Adriano, Arturo Abdelnour, Carolina Soley, et al.. (2012). Prospective epidemiologic surveillance of invasive pneumococcal disease and pneumonia in children in San José, Costa Rica. Vaccine. 30(13). 2342–2348. 15 indexed citations

19.

Andrade, Ana Lúcia, Renato Maurício de Oliveira, María Aparecida Vieira, et al.. (2011). Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Goiânia, Brazil. Vaccine. 30(10). 1901–1909. 31 indexed citations

20.

Black, Steven, Eric K. France, Daniel J. Isaacman, et al.. (2007). Surveillance for Invasive Pneumococcal Disease During 2000–2005 in a Population of Children Who Received 7-Valent Pneumococcal Conjugate Vaccine. The Pediatric Infectious Disease Journal. 26(9). 771–777. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact